The Two Pillars of Treatment: Medication and Risk Control

Treatment for vascular parkinsonism (VaP) is different from traditional Parkinson’s disease. While traditional treatment focuses almost entirely on replacing dopamine, the “standard of care” for VaP focuses on two pillars: an individualized trial of Parkinson’s medication and clinician-directed protection of your brain’s blood vessels ^[1][2].

It is important to understand that treating vascular risk factors primarily reduces the risk of future vascular events rather than reliably reversing the walking and balance issues you may already have. Instead, the goal is to improve your current mobility where possible and, most importantly, to prevent further brain injury and future strokes ^[3][4].

Medication Safety Warning

Never start, combine, or stop levodopa, blood-pressure medications, statins, antiplatelets, or anticoagulants without direct medical advice from your prescribing clinician.

• Orthostatic Blood Pressure: Levodopa and blood pressure medications can safely lower your blood pressure, but they can also cause it to drop dangerously when you stand up, leading to dizziness or falls. Ask your clinician if you should keep a log of seated and standing blood pressure at home.
• Levodopa Side Effects: Contact your prescriber if you experience hallucinations, severe sleepiness, nausea, or involuntary movements (dyskinesia). Never stop levodopa abruptly; it must be tapered under medical supervision.
• Bleeding Risks: Report any new or unusual bruising or bleeding if you are taking antiplatelets or anticoagulants.

Pillar 1: The Levodopa Trial

Because VaP can look so much like idiopathic Parkinson’s—and because many people have “mixed” disease—most neurologists will recommend a supervised, time-limited trial of levodopa (often branded as Sinemet) ^[5][6].

• Setting Expectations: Observational studies estimate that only about 30% of people with VaP respond significantly to levodopa ^[7]. You are more likely to see a benefit if your symptoms started suddenly after a stroke in a specific movement center or if you have “mixed” disease (both VaP and Parkinson’s) ^[1][2]. Benefit may be subtle.
• The Protocol: A “trial” involves your doctor gradually adjusting the dose over several weeks ^[8]. There is no universal dosage protocol for VaP. Do not self-escalate the dose to try and force a response, as higher doses increase the risk of side effects.
• Measuring Success: Your doctor will look for objective improvements in your “speed” during walking, your ability to turn around, or a reduction in muscle stiffness ^[9]. If there is no clear benefit, the medication is safely tapered off by your clinician to avoid unnecessary side effects ^[2].

Pillar 2: Vascular Risk Management

This is the most critical part of your long-term care. By managing the health of your blood vessels, you are directly treating the underlying cause of VaP ^[1]. These targets are highly individualized.

Blood Pressure Control

High blood pressure is a leading cause of the small vessel damage that drives VaP ^[1].

• The Target: While some stroke prevention guidelines suggest an example target of less than 130/80 mmHg for secondary stroke prevention, this is not a universal rule ^[4]. The goal depends heavily on your age, frailty, kidney function, stroke mechanism, and whether you experience orthostatic symptoms.
• The Balancing Act: For older adults or those with parkinsonism, “lower” isn’t always “better.” If your blood pressure drops too low when you stand up (orthostatic hypotension), it can increase your risk of falls. Your doctor will tailor this target based on your safety ^[10].

Cholesterol and Lipid Management

Even if your cholesterol isn’t “high” by standard laboratory measures, “intensive” lowering is recommended to protect your brain’s arteries ^[11].

• The Target: The goal for patients with established atherosclerotic disease or prior ischemic stroke is typically an LDL (bad) cholesterol of less than 70 mg/dL ^[12]. Again, this goal is tailored to your specific comorbidities.
• Medications: High-intensity statins (such as atorvastatin or rosuvastatin) are the primary tools used to reach this goal ^[13]. If statins alone aren’t enough, your doctor may add medications like ezetimibe ^[14].

Clinician-Directed Stroke Prevention

Preventing new blood clots requires specific medical strategies tailored to the exact cause of your vascular disease.

• Antiplatelets vs. Anticoagulants: These are different treatments. If you had a non-cardioembolic ischemic stroke or TIA, you may be prescribed an antiplatelet medication (like aspirin or clopidogrel). However, if you have atrial fibrillation or another cardioembolic source, you generally require an anticoagulant (a “blood thinner”) instead ^[15]. VaP or white-matter disease on an MRI does not automatically justify antiplatelet therapy.
• Dual Antiplatelet Therapy (DAPT): Using two antiplatelets at once (like aspirin plus clopidogrel) is reserved for selected acute minor ischemic strokes or high-risk TIAs after a hemorrhage has been ruled out. It is typically used for a short duration (e.g., 21-90 days) and is not a routine long-term treatment for VaP ^[16][15].

Managing Other Risks

Vascular health is a whole-body effort. Your care plan should also include ^[1]:

• Diabetes and Sleep Apnea Review: Managing blood sugar and addressing sleep apnea to protect blood vessels.
• Smoking Cessation: Stopping smoking is one of the most impactful things you can do to stop the progression of vascular damage.
• Physical Activity: While walking may be difficult, regular physical therapy and movement help keep the remaining blood vessels healthy and improve your brain’s ability to compensate for old injuries.